Baroflex Activation Therapy for Refractory Congestive Heart Failure: Anesthetic Implications.

Carlo Maria De Filippo,Goffredo Liberatoscioli,Nicola Testa,Matteo Santamaria, Monica Mucciarone,Pietro Modugno,Massimo Massetti,Edoardo Gronda,Emilio Vanoli,Cosimo Sacra,Eugenio Caradonna

Journal of cardiothoracic and vascular anesthesia（2016）

引用 1|浏览20

暂无评分

摘要

CONGESTIVE HEART FAILURE (HF) is an increasingly frequent healthcare problem. 1 Roger V.L. Epidemiology of heart failure. Circ Res. 2013; 113: 646-659 Crossref PubMed Scopus (1088) Google Scholar Despite currently available drug and device therapies, 25% to 35% of patients with HF and reduced left ventricular ejection fraction remain in New York Heart Association (NYHA) class III. 2 Yancy C.W. Jessup M. Bozkurt B. et al. 2013 ACCF/AHA guideline for the management of heart failure: A report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol. 2013; 62: e147-e239 Abstract Full Text Full Text PDF PubMed Scopus (4715) Google Scholar

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要